Core Viewpoint - Hawkins, Inc. has acquired the assets of WaterSurplus, enhancing its water treatment solutions and expanding its portfolio of value-added products, which aligns with its strategy to grow its higher-margin business [1][2][3] Financial Highlights - Hawkins generated $919 million in revenue for fiscal 2024 and anticipates its Water Treatment business to exceed $500 million in revenue in fiscal year 2026 [3][7] - WaterSurplus generated adjusted EBITDA of approximately $10 million for the fiscal year ending December 31, 2024 [6] - Hawkins closed on an amended $400 million revolving credit facility, increasing from $250 million, to fund the acquisition [6] Business Highlights - The acquisition of WaterSurplus is expected to be accretive to Hawkins' earnings per share in fiscal year 2027 and will improve the margin profile of Hawkins' current Water Treatment business [6] - Hawkins has completed 13 acquisitions over the last 5 years to build its Water Treatment business, indicating a strong integration capability [3] - WaterSurplus offers patented filtration products that reduce operational costs and enhance efficiency, which will complement Hawkins' existing offerings [9]

Core Insights - Hawkins, Inc. reported earnings of 72 cents per share for Q3 fiscal 2025, a slight increase from 71 cents in the same quarter last year, but below the Zacks Consensus Estimate of 78 cents [1] - The company achieved revenues of $226.2 million, representing an 8% year-over-year increase, and surpassed the Zacks Consensus Estimate of $219.2 million [2] Segment Performance - The Water Treatment segment saw a significant sales increase of 22% year over year, reaching $99.8 million, driven by acquisitions and higher sales volumes [3] - The Industrial segment experienced a 1% decline in sales to $92 million, impacted by lower selling prices and changes in product mix [4] - Sales in the Health and Nutrition segment rose by 3% year over year to $34.5 million, attributed to increased sales of manufactured products [4] Financial Overview - At the end of the quarter, Hawkins had cash and cash equivalents of approximately $8.3 million, a 10% increase sequentially, while long-term debt rose to about $103.9 million, an 11% increase from the previous quarter [5] - The company generated an operating cash flow of around $80.3 million for the nine months ending December 29, 2024 [5] Future Outlook - Hawkins anticipates continued growth in the Water Treatment and Health and Nutrition segments, while expecting the Industrial segment to perform similarly to the first nine months of fiscal 2025 [6] Stock Performance - Hawkins' shares have increased by 89.9% over the past year, contrasting with a 14.5% decline in the Zacks Chemicals Specialty industry [7]

Core Viewpoint - Hawkins has successfully acquired all assets of Amerochem, a rival water treatment chemicals and equipment company, leading to a 5.6% increase in its stock despite a market downturn [1]. Company Acquisition - The acquisition of Amerochem is seen as a strategic move, with Hawkins CEO highlighting the strong relationships Amerochem has built over 30 years with customers, suppliers, and employees, which Hawkins aims to maintain and expand [2]. - Details regarding the financial terms of the acquisition were not disclosed, leaving investors without specific information to assess the deal's value [3]. Market Expansion - Hawkins indicated that the acquisition will expand its market presence, particularly in North Carolina, although no specifics on market size or profitability were provided [3]. Investor Sentiment - Investors appear to be optimistic about the acquisition, trusting that Hawkins made a sound decision, although they lack detailed information [4]. - The stock is currently trading at over 27 times earnings, with analysts projecting a modest annual earnings growth of around 7% over the next five years [5]. Financial Health - Hawkins reported strong free cash flow of $80 million over the last 12 months, aligning with its earnings, and maintains a manageable debt level of less than $120 million against a market capitalization of $2.2 billion [5]. Overall Assessment - The company is viewed as a solid business, but its stock is considered overpriced given the lack of detailed information on the Amerochem acquisition [6].

Core Insights - Hawkins, Inc. has completed the acquisition of Amerochem Corporation, a distributor of water treatment chemicals and equipment primarily in North Carolina [1][2] - This acquisition marks Hawkins' second in North Carolina and expands its Water Treatment locations to 50 across the U.S. [2] - The CEO of Hawkins expressed confidence in maintaining and expanding relationships built by Amerochem over the past 30 years [2] Company Overview - Hawkins, Inc. was founded in 1938 and specializes in water treatment and specialty ingredients, providing products for Industrial, Water Treatment, and Health & Nutrition sectors [3] - The company is headquartered in Roseville, Minnesota, operates 62 facilities in 28 states, and generated $919 million in revenue for fiscal 2024 [3] - Hawkins employs approximately 1,000 people and focuses on delivering value through customer service, quality products, and personalized applications [3]

Thursday was a good day for many stocks. However, Hawkins (HWKN -8.44%) wasn't one of those winners. The market generally shunned the diversified chemical company, sending its shares down by almost 8% in late-session trading. They were reacting to its third-quarter fiscal 2025 earnings report in which key metrics fell short of expectations. By contrast, the bellwether S&P 500 index was moving slightly higher, at nearly 0.4%.New records posted, yet the figures fell shortHawkins's sell-off occurred despite it ...

Hawkins (HWKN) came out with quarterly earnings of $0.72 per share, missing the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.71 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -7.69%. A quarter ago, it was expected that this chemical maker would post earnings of $1.18 per share when it actually produced earnings of $1.16, delivering a surprise of -1.69%.Over the last four quarters, the company h ...

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date. CLASS Shares Outstanding at January 24, 2025 Common Stock, par value $.01 per share 20,929,004 HAWKINS, INC. INDEX TO FORM 10-Q | | | Page | | --- | --- | --- | | PART I. | FINANCIAL INFORMATION | | | Item 1. | Financial Statements (unaudited): | | | | Condensed Consolidated Balance Sheets – December 29, 2024 and March 31, | 1 | | | 2024 | | | | Condensed Consolidated Statements of I ...

ROSEVILLE, Minn., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced results for the nine months ended December 29, 2024, its third quarter of fiscal 2025. Third Quarter Fiscal Year 2025 Highlights: Record third quarter results for revenue, gross profit, operating income, and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“adjusted EBITDA”), a non-GAAP measure.Overall revenue growth of 8%, once again driven by the Water Treatment segment growth of 22% ov ...

ROSEVILLE, Minn., Jan. 29, 2025 (GLOBE NEWSWIRE) --  The Board of Directors of Hawkins, Inc. (Nasdaq: HWKN), at its meeting on January 29, 2025, declared a quarterly cash dividend of $0.18 per share, payable February 28, 2025, to shareholders of record at the close of business on February 14, 2025. Hawkins has consistently paid out a dividend since 1985. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, distributes, ble ...

ROSEVILLE, Minn., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) announced today that it expects to release financial results for its fiscal 2025 third quarter ended December 29, 2024 after the market closes on January 29, 2025 at approximately 4:10 p.m. Eastern Time. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading specialty chemical and ingredients company that formulates, distributes, blends, and manufactures products for its Industrial, Water Treatment, and Health ...